Trial Analysis
Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
READ MORE →
Holistic Data Analysis
Improving knowledge about the treatment effect
READ MORE →
Holistic Data Analysis
Mid-size US biotech company, phase 3 oncology trial
READ MORE →